Middle Molecule Find

Rulebook › V-tags › V360

V360 Reuse quality assurance

Written V0360 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 178 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR 494.50(b)(1)

14 Quality assurance (internal standards and clinical outcomes)

The criteria chosen as the internal standards of a facility shall be documented in its policy and/or procedure manual. Process review should be part of the activity of the individual carrying out the process, and oversight of that review by another qualified member of the staff or a group of staff members should affirm, modify, or repeat these observations to confirm or improve the process.

Clinical outcomes serve as the most important indicator of quality of all dialysis treatment practices including reuse. Final oversight is the responsibility of the medical director. See Table 2 for a summary of the audit schedule.

14.1 Records

A record of review, comments, trend analysis, and conclusions arising from QA practices serve as a foundation for future review and as documentation to external evaluation.

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

A.14 Quality assurance

The FDA’s 1987 compliance policy guide (7124.16) advises reuse practitioners to establish the following: (a) adequate device cleaning and sterilization; (b) the lack of adverse effects on device quality or physical characteristics; and (c) certainty that the device remains safe, reliable, and effective for its intended use. The [AAMI RDD] Committee believes that compliance with those recommendations necessitates use of regularly examined reprocessing procedures that are based on methods of demonstrated effectiveness and are carried out under conditions safe to the patient and the personnel.

Table 2—Quality assurance audit schedule
MonthlyQuarterlySemi-AnnuallyAnnually
Patient information policy (14.3)X
Equipment manuals and procedures (14.4)X
Equipment maintenance and repair policies (14.4)X
Environmental safety (8.1)X
Environmental safety (8.2)X
Environmental safety (8.4)X
Reprocessing supplies (9)X
Water treatment* (11.4.1.5)X
Hemodialyzer labeling (10)X
Reprocessing procedures** (14.8)XX
Procedures for preparation for dialysis (14.9)X

Typed by hand from pages 179-180 of Appendix H, because the PDF's table doesn't extract cleanly. Open page 179 (the full PDF).

* More frequent monitoring may be required initially as described in 11.4.1.5.
**These functions may allow for a less frequent review period, as indicated in their respective sections, according to the specified circumstances. **
Note: Numbers in parentheses refer to AAMI sections.

Additional Guidance:

The QAPI Condition at § 494.100 (Tag V625) requires the facility’s quality improvement program to reflect the complexity of the dialysis facility’s organization and the services it provides. In other words, if a dialysis facility’s services include reuse, reuse audits must be performed on the required schedule and reported in the QAPI activities. For many of the audits, there is a two-tier system of review required: the review of the process by the person assigned (i.e., reprocessing by the reuse technician), and oversight of that review by another person qualified to do so (i.e., the technical supervisor observing the reuse technician performing reprocessing).

If the facility participates in a centralized reprocessing program, the QA audits done in the reprocessing facility must be provided to the patient treatment facility and reviewed as part of the QAPI of that facility. Any complaints related to the reprocessing of dialyzers would need to be reported to the patient treatment facility sending the applicable dialyzers.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 178 (the full 469-page PDF) before quoting it.

Connected tags

Tags whose guidance points here